B · Normal
[Beijing Xiantong International Pharmaceutical Technology Co., Ltd.-B passed the Hong Kong Stock Exchange listing hearing] On October 28, Livermore Securities showed that Beijing Xiantong International Pharmaceutical Technology Co., Ltd.-B updated the post-hearing information set, which means that the company’s Hong Kong Stock Exchange IPO passed the hearing.
Comments